January 31, 2019European Respiratory JournalOpen Access

The impact of the new Global Lung Function InitiativeTLCOreference values on trial inclusion for patients with idiopathic pulmonary fibrosis

View Full Paper

Ask AI

Bookmark

Abstract

Adopting the new Global Lung Function Initiative TLCOreference values may positively impact clinical trial eligibility for IPF patientshttp://ow.ly/bOMn30n2YOP

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wapenaar et al. (2019) studied this question.

synapsesocial.com/papers/6a6f2bf778a11c550e08d9ae https://doi.org/10.1183/13993003.01895-2018

View Full Paper

Ask AI

Bookmark

Abstract

Adopting the new Global Lung Function Initiative TLCOreference values may positively impact clinical trial eligibility for IPF patientshttp://ow.ly/bOMn30n2YOP

The impact of the new Global Lung Function InitiativeTLCOreference values on trial inclusion for patients with idiopathic pulmonary fibrosis

Abstract

Discussion

Cite This Study

The impact of the new Global Lung Function InitiativeTLCOreference values on trial inclusion for patients with idiopathic pulmonary fibrosis

Abstract

Discussion

Cite This Study

Also Consider

Also Consider